Literature DB >> 31568307

Onset and Resolution of Chiari Malformations and Hydrocephalus in Syndromic Craniosynostosis following Posterior Vault Distraction.

Lawrence O Lin1, Rosaline S Zhang1, Ian C Hoppe1, J Thomas Paliga1, Jordan W Swanson1, Scott P Bartlett1, Jesse A Taylor1.   

Abstract

BACKGROUND: Patients with syndromic craniosynostosis have an increased incidence of progressive hydrocephalus and Chiari malformations, with few data on the relative benefit of various surgical interventions. The authors compare the incidence and resolution of Chiari malformations and hydrocephalus between patients undergoing posterior vault distraction osteogenesis (PVDO) and patients undergoing conventional cranial vault remodeling.
METHODS: Patients with syndromic craniosynostosis who underwent cranial vault surgery from 2004 to 2016 at a single academic hospital, with adequate radiographic assessments, were reviewed. Demographics, interventions, the presence of a Chiari malformation on radiographic studies and hydrocephalus requiring shunt placement were recorded. Mann-Whitney U and Fisher's exact tests were used as appropriate.
RESULTS: Forty-nine patients underwent PVDO, and 23 patients underwent cranial vault remodeling during the study period. Median age at surgery (p = 0.880), sex (p = 0.123), and types of syndrome (p = 0.583) were well matched. Patients who underwent PVDO had a decreased incidence of developing Chiari malformations postoperatively compared with the cranial vault remodeling cohort (2.0 percent versus 17.4 percent; p = 0.033). Not surprisingly, no significant difference was found between the groups with regard to the incidence of postoperative hydrocephalus requiring shunt placement (PVDO, 4.1 percent; cranial vault remodeling, 4.3 percent; p = 0.999).
CONCLUSIONS: As expected, PVDO did not significantly affect intracranial hydrodynamics to the extent that hydrocephalus shunting rates were different for patients with syndromic craniosynostosis. However, PVDO was associated with a reduced risk of developing a Chiari malformation; however, prospective evaluation is needed to determine causality. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

Entities:  

Mesh:

Year:  2019        PMID: 31568307     DOI: 10.1097/PRS.0000000000006041

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  6 in total

1.  Posterior cranial vault distraction osteogenesis in the immunocompromised patient.

Authors:  John S Sullivan; Alicia E Snider; Jeffrey Farrington; J Mason Shiflett; Kristin J Weaver; Laura S Humphries; Ian C Hoppe
Journal:  Childs Nerv Syst       Date:  2021-05-10       Impact factor: 1.475

2.  Craniosynostosis and hydrocephalus: relevance and treatment modalities.

Authors:  Paolo Frassanito; Davide Palombi; Gianpiero Tamburrini
Journal:  Childs Nerv Syst       Date:  2021-04-07       Impact factor: 1.475

3.  Syndrome-related outcomes following posterior vault distraction osteogenesis.

Authors:  Cassio Eduardo Raposo-Amaral; Yuri Moresco de Oliveira; Rafael Denadai; Cesar Augusto Raposo-Amaral; Enrico Ghizoni
Journal:  Childs Nerv Syst       Date:  2021-04-18       Impact factor: 1.475

Review 4.  Syndromic Hydrocephalus.

Authors:  Kaamya Varagur; Sai Anusha Sanka; Jennifer M Strahle
Journal:  Neurosurg Clin N Am       Date:  2022-01       Impact factor: 2.509

Review 5.  The management of Chiari malformation type 1 and syringomyelia in children: a review of the literature.

Authors:  Veronica Saletti; Mariangela Farinotti; Paola Peretta; Luca Massimi; Palma Ciaramitaro; Saba Motta; Alessandra Solari; Laura Grazia Valentini
Journal:  Neurol Sci       Date:  2021-09-30       Impact factor: 3.307

6.  Extended experience in parieto-occipital expansion surgery by meander technique-clinical and radiological evaluation.

Authors:  Valentina Pennacchietti; Matthias Schulz; Anna Tietze; Karin Schwarz; Ulrich-Wilhelm Thomale
Journal:  Childs Nerv Syst       Date:  2021-09-16       Impact factor: 1.475

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.